Application
17494370 · COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
Filed 2021-10-05 · Abandoned The official file ↗ · Art unit 1625 · Examiner D Margaret M Seaman Typical · CPC A61K 31/506 · Rigel Pharmaceuticals, Inc. · Klarquist Sparkman, LLP (Rigel)
Office actions
1
first was Non-final rejection
RCEs
0
no appeal
To first action
34.6 mo
to disposition 41.2 mo
Statutes raised
102 DP
1 actions read